Tumor Tissue-Based Biomarkers
نویسندگان
چکیده
Cancer Control 219 detailed diagnostic and prognostic categorization. Recently published gene expression and proteomic profiling data indicate new candidate molecules involved in melanoma pathogenesis, which are currently validated. This ongoing process of biomarker identification and validation results in a rapidly changing molecular view and classification of cutaneous malignancies, which holds the promise of improving not only our prognostic classification systems, but also our diagnostic and therapeutic potential. This article provides an overview of the currently known serologic and immunohistochemical biomarker in melanoma.
منابع مشابه
THE EREXPRESSION OF P16 AND HER2/NEW BIOMARKERS IN BLADDER URETHRAL TUMOR AND ITS ASSOCIATION WITH HISTOPATHOLOGIC CHARACTERISTICS
Background & Aims: In addition to the clinical and histological factors that are able to differentiate between low grade tumors and high grade tumors in bladder urothelial tumors, a number of biomarkers have also been proposed that may be useful in evaluating tumor grade, outcome, and prognosis. The purpose of the present study was to investigate the relationship between the amount of Her2/neu ...
متن کاملThe Expression Of Biomarkers In Invasive Ductal Carcinoma Of Breast Through Tissue Array Method And Its Comparison With Clinicopathologic Features
Background and Objective: In this study, we explored expression rate, some biomarkers affecting the prognosis of the breast carcinoma, and the relationship between these markers and clinicopathologic features of the disease as well as the relationship between each of these markers through a tissue array technique. Materials and Methods: This study was an observational and cross-sectional st...
متن کاملThe Interaction Between the Expression of Proliferative Biomarkers and Clinical Characteristics in Breast Cancer
Introduction: Proliferation of cancer cells and the potential of metastasis depend on the activity of different biomarkers such as proliferative ones. Proliferative biomarkers including ki-67, cyclin E1, cyclin D1, p27, and p21 were analyzed through immunohistochemistry (IHC) in previous studies. Methods: The current study aimed at investigating the utilizing role of RT-PCR in studying prolife...
متن کاملThe Interaction Between the Expression of Proliferative Biomarkers and Clinical Characteristics in Breast Cancer
Introduction: Proliferation of cancer cells and the potential of metastasis depend on the activity of different biomarkers such as proliferative ones. Proliferative biomarkers including ki-67, cyclin E1, cyclin D1, p27, and p21 were analyzed through immunohistochemistry (IHC) in previous studies. Methods: The current study aimed at investigating the utilizing role of RT-PCR in studying prolife...
متن کاملA review on miRNAs as new biomarkers for colorectal cancer
Background & Objective: Since colorectal cancer does not often have phenotypic symptoms in the early stages, the study of biomarkers for the diagnosis and prognosis of the tumor is very important. MicroRNAs are one of the most important biomarkers which attract the attention of many researchers due to a variety of reasons, including their non-invasive nature; these molecules are a group of non-...
متن کاملBacterial and tissue biomarkers of gastric cancer: new findings and future perspectives: review article
Gastric cancer (GC) is the second leading cause of cancer-related deaths worldwide. It has been proposed that the specific genotypes of Helicobacter pylori (H. pylori) are the causative agents in the development of gastroduodenal diseases, such as chronic atrophic gastritis, peptic ulcerations, and GC. However, disease progression to GC occurs in only a small proportion of infected patients. Re...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2009